Selol nanocapsules with a poly(methyl vinyl ether-co-maleic anhydride) shell conjugated to doxorubicin for combinatorial chemotherapy against murine breast adenocarcinoma in vivo.

@article{Ganassin2018SelolNW,
  title={Selol nanocapsules with a poly(methyl vinyl ether-co-maleic anhydride) shell conjugated to doxorubicin for combinatorial chemotherapy against murine breast adenocarcinoma in vivo.},
  author={Rayane Ganassin and Frederico Hillesheim Horst and Nichollas Serafim Camargo and Sacha Braun Chaves and Paulo C{\'e}sar de Morais and Ewa Mosiniewicz-Szablewska and Piotr Suchocki and Jo{\~a}o Paulo Figueir{\'o} Longo and Ricardo Bentes de Azevedo and Lu{\'i}s Alexandre Muehlmann},
  journal={Artificial cells, nanomedicine, and biotechnology},
  year={2018},
  pages={1-7}
}
Nanocapsules containing selol and doxorubicin (NCS-DOX) with an oily core of selol and a shell of poly(methyl vinyl ether-co-maleic anhydride) covalently conjugated to doxorubicin were developed in a previous work. In this study, these nanocapsules showed a similar antitumour effect in comparison to the free doxorubicin (DOX) treatment, but showed no… CONTINUE READING